Abstract:Tumor necrosis factor α (TNFα)-based immunotherapy is the vital host defense system against the progression of gastric cancer (GC) as a pro-inflammatory and pro-apoptotic cytokine. However, resistance limits its therapeutic efficiency. Therefore, an increasing number of studies are focusing on the development of drugs or methods with which to enhance the treatment efficacy of TNFα. Nuclear receptor subfamily 4 group A member 1 (NR4A1) has been shown to exert antitumor effects through several mechanisms, such as by inhibiting proliferation, as well as pro-apoptotic and potent pro-oxidant effects. In this study, we examined the effects and mechanisms of action of NR4A1 on the apoptosis of GC cells treated with TNFα, with particular focus on mitochondrial homeostasis. We found that TNFα treatment decreased NR4A1 expression. Moreover, the overexpression of NR4A1 in the presence of TNFα further increased GC cell apoptosis. Mechanistically, the overexpression of NR4A1 augmented caspase-9-dependent mitochondrial apoptosis, as evidenced by reduced mitochondrial membrane potential, reactive oxygen species (ROS) overproduction, mitochondrial permeability transition pore (mPTP) opening and the leakage of cytochrome c (Cyt-c) leakage. Moreover, NR4A1 overexpression also evoked mitochondrial energy disorder via the suppression of mitochondrial respiratory complex expression. Furthermore, we found that TNFα treatment activated Parkin-dependent mitophagy. Excessive Parkin-dependent mitophagy blocked mitochondrial apoptosis, undermining the toxic effects of TNFα on cells. However, NR4A1 overexpression suppressed Parkin-dependent mitophagy via the inhibition of c-Jun N-terminal kinase (JNK). Re-activation of the JNK/Parkin pathway abrogated the inhibitory effects of NR4A1 on mitophagy, eventually limiting cell apoptosis. Collectively, this study confirmed that NR4A1 sensitizes GC cells to TNFα-induced apoptosis through the inhibition of JNK/Parkin-dependent mitophagy.

Inhibition of ANO1/TMEM16A Induces Apoptosis in Human Prostate Carcinoma Cells by Activating TNF-α Signaling.

Inhibition of Ca2+-activated Cl− Channel ANO1/TMEM16A Expression Suppresses Tumor Growth and Invasiveness in Human Prostate Carcinoma

Involvement of TMEM16A/ANO1 Upregulation in the Oncogenesis of Colorectal Cancer

Involvement of TMEM16A/ANO1 upregulation in the oncogenesis of colorectal cancer.

Inhibition of Calcium-Activated Chloride Channel ANO1 Suppresses Proliferation and Induces Apoptosis of Epithelium Originated Cancer Cells

Influence of inhibitor of signal transduction on the cell apoptosis induced by TNF β

Inhibition of Ca2+ -Activated Chloride Channel ANO1 Suppresses Ovarian Cancer Through Inactivating PI3K/Akt Signaling.

Inhibition of Calcium-Activated Chloride Channel ANO1/TMEM16A Suppresses Tumor Growth and Invasion in Human Lung Cancer

Downregulation of ANO1 activity in PC‐9 cells modulated by a new novel candidate TMEMinh001

Role of ANO1 in Tumors and Tumor Immunity

Inhibition of ANO1 by Cis- and Trans-Resveratrol and Their Anticancer Activity in Human Prostate Cancer PC-3 Cells

High ANO1 expression is a prognostic factor and correlated with an immunosuppressive tumor microenvironment in pancreatic cancer

ANO1‐Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer‐Associated Fibroblasts

Fusobacterium nucleatum prevents apoptosis in colorectal cancer cells via the ANO1 pathway

Protease Nexin 1 Induces Apoptosis of Prostate Tumor Cells Through Inhibition of X-Chromosome-Linked Inhibitor of Apoptosis Protein

NKX3.1 potentiates TNF-α/CHX-induced apoptosis of prostate cancer cells through increasing caspase-3 expression and its activity

ANO1 reprograms cholesterol metabolism and the tumor microenvironment to promote cancer metastasis

Promoter hypermethylation as a novel regulator of ANO1 expression and function in prostate cancer bone metastasis

Annonaceous Acetogenin Mimic AA005 Induces Cancer Cell Death Via Apoptosis Inducing Factor Through a Caspase-3-independent Mechanism

NR4A1-induced Increase in the Sensitivity of a Human Gastric Cancer Line to TNFα-mediated Apoptosis is Associated with the Inhibition of JNK/Parkin-dependent Mitophagy.

ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancer